Floatz logo

ASPARAGINASE

T-cell Childhood Acute Lymphoblastic Leukemia

National Cancer Institute (NCI)protein_peptidePhase 3Dormant
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
58/ 100
Competitive Position
95/ 100

Competitive context

18 Active assets in the T-cell Childhood Acute Lymphoblastic Leukemia cohort.

Asset / SponsorPhaseRating
VINCRISTINE SULFATE
National Cancer Institute (NCI)
Phase 3BBB
METHOTREXATE
National Cancer Institute (NCI)
Phase 3BBB
PEGASPARGASE
National Cancer Institute (NCI)
Phase 3BBB
DEXAMETHASONE
National Cancer Institute (NCI)
Phase 3BBB
Cyclophosphamide
National Cancer Institute (NCI)
Phase 3BB

View all 37 →

Same molecule, other indications

ASPARAGINASE is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →
lymphoblastic lymphomaDormant
BBB
Indicative ·
75 / 100
View asset →
childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →